Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04446117
Title Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Exelixis
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Atezolizumab + Cabozantinib

Abiraterone + Prednisone

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.